# SPI Pharma, SAS – FDA Inspection, Apr 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/spi-pharma-sas/d858a97a-f3ad-4dbb-8197-924c2b9cf511
Source feed: FDA_Inspections

> FDA inspection 1273714 of SPI Pharma, SAS, April 26, 2024. Classification: Voluntary Action Indicated (VAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1273714
- Company Name: SPI Pharma, SAS
- Inspection Date: 2024-04-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1125749 - 2018-06-29
- FDA Inspection 968552 - 2016-02-12
- FDA Inspection 826851 - 2013-02-14
- FDA Inspection 621071 - 2009-09-29

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/mra-v-millarw/ea28ecad-65ef-4cbe-9f4b-fa460dcef90f)

Company: https://www.keypedia.com/companies/spi-pharma-sas/ec8fe21b-d621-4f9c-86ff-0816fa764ec5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c